AIM IMMUNOTECH INC. Increase (Decrease) in Interest Payable, Net
AIM IMMUNOTECH INC. (AIM) reported Increase (Decrease) in Interest Payable, Net of $231.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-31.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInterestPayableNet · last filed 2022-03-31
- AIM IMMUNOTECH INC. increase (decrease) in interest payable, net for the quarter ending 2020-12-31 was $1.00K.
- AIM IMMUNOTECH INC. increase (decrease) in interest payable, net for the quarter ending 2020-09-30 was $0.00.
- AIM IMMUNOTECH INC. increase (decrease) in interest payable, net for the quarter ending 2020-06-30 was $91.00K.
- AIM IMMUNOTECH INC. increase (decrease) in interest payable, net for the quarter ending 2020-03-31 was $139.00K.
- AIM IMMUNOTECH INC. increase (decrease) in interest payable, net for fiscal 2020 was $231.00K, a 79.07% increase from fiscal 2019.
- AIM IMMUNOTECH INC. increase (decrease) in interest payable, net for fiscal 2019 was $129.00K.
| Period end | Increase (Decrease) in Interest Payable, Net 3 month | Increase (Decrease) in Interest Payable, Net 6 month | Increase (Decrease) in Interest Payable, Net 9 month | Increase (Decrease) in Interest Payable, Net 12 month |
|---|---|---|---|---|
| 2020-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $1.00K derived: sum of 2 quarters · filed 2022-03-31 | $92.00K derived: sum of 3 quarters · filed 2022-03-31 | $231.00K 10-K · filed 2022-03-31 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $91.00K derived: sum of 2 quarters · filed 2021-11-15 | $230.00K 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $91.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $230.00K 10-Q · filed 2021-08-16 | ||
| 2020-03-31 | $139.00K 10-Q · filed 2021-05-17 | |||
| 2019-12-31 | $129.00K 10-K · filed 2021-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |